Skip to main content

Table 3 Fasted levels of metabolic blood markers in STZ-treated hyperglycemic, STZ-treated euglycemic, and vehicle-treated control rats

From: Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia

  Control STZ, Euglycemic STZ, Hyperglycemic
Factor 2 Weeks 8 Weeks 2 Weeks 8 Weeks 2 Weeks 8 Weeks
Glucose (mM) 7.0 ± 1.2 6.3 ± 0.4 7.0 ± 1.1 5.9 ± 0.6 24.6 ± 7.2* 28.8 ± 5.1*
Insulin (ng/mL) 0.65 ± 0.41 1.36 ± 0.69 0.67 ± 0.66 0.79 ± 0.57 0.78 ± 0.46 0.33 ± 0.33*
NEFA (nM) 0.20 ± 0.10 0.40 ± 0.13 0.31 ± 0.05 0.20 ± 0.12* 0.30 ± 0.22 0.24 ± 0.14*
Triglyceride (nM) 0.79 ± 0.05 0.81 ± 0.35 0.67 ± 0.17 0.66 ± 0.14 0.80 ± 0.45 0.55 ± 0.29*
NE (ng/mL) 0.10 ± 0.05 0.11 ± 0.06 0.10 ± 0.14 0.10 ± 0.03 0.10 ± 0.06 0.24 ± 0.09*
  1. Mean ± SD.
  2. * p < 0.05 to age-matched control, † p < 0.05 to age-matched STZ, euglycemic, one-way ANOVA, Bonferroni post hoc